on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group, Inc. Discloses Position in Mural Oncology plc
The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc under Rule 8.3 of the Irish Takeover Panel Act, 1997. This pertains to securities representing more than 1% in relevant interests. The disclosure was made on 25 November 2025, with the position held as of 24 November 2025.
The Vanguard Group's relevant securities in Mural Oncology include $0.01 ordinary shares totaling 243,005, representing 1.41%. A recent transaction involved the sale of 46,206 $0.01 ordinary shares at a unit price of 2.09 USD.
No cash-settled or stock-settled derivatives were disclosed, nor were there any indemnity arrangements, agreements, or understandings involving options or derivatives. There was also no attachment of a Supplemental Form 8 to the disclosure.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news